ID

18993

Description

Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193232

Link

https://clinicaltrials.gov/show/NCT00193232

Keywords

Versions (1)
  1. 11/29/16 11/29/16 -
Uploaded on

November 29, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00193232

English

Eligibility Prostate Cancer NCT00193232

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate cancer, and objective evidence of metastatic disease
Description

Prostate carcinoma | Neoplasm Metastasis Evidence of

Data type

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C0332120
progression while receiving androgen ablation therapy
Description

androgen suppression | Disease Progression

Data type

boolean

Alias
UMLS CUI [1]
C1515985
UMLS CUI [2]
C0242656
no previous chemotherapy
Description

Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
measurable or evaluable disease in conjunction with elevated serum psa levels
Description

Measurable Disease | Evaluable Disease | Serum Prostate Specific Antigen Increased

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
UMLS CUI [3]
C1883014
ecog performance status 0, 1, or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, liver and kidney function
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
voluntarily provide written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Clinical Trial Eligibility Criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
moderate or severe peripheral neuropathy
Description

Peripheral Neuropathy Moderate | Peripheral Neuropathy Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C0205081
UMLS CUI [2,1]
C0031117
UMLS CUI [2,2]
C0205082
age < 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
other serious medical conditions that may interfere with protocol therapy
Description

Medical condition Serious Interferes with Protocol Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C2348563
UMLS CUI [1,5]
C0087111
other active malignancies
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
history of treatment for other invasive cancers within 3 years
Description

Therapeutic procedure Invasive cancer

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0677898
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

Clinical Trial Eligibility Criteria Additional

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
Back to the top of the page

Similar models

Eligibility Prostate Cancer NCT00193232

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma | Neoplasm Metastasis Evidence of
Item
prostate cancer, and objective evidence of metastatic disease
boolean
C0600139 (UMLS CUI [1])
C0027627 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
androgen suppression | Disease Progression
Item
progression while receiving androgen ablation therapy
boolean
C1515985 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
Chemotherapy
Item
no previous chemotherapy
boolean
C0392920 (UMLS CUI [1])
Measurable Disease | Evaluable Disease | Serum Prostate Specific Antigen Increased
Item
measurable or evaluable disease in conjunction with elevated serum psa levels
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1883014 (UMLS CUI [3])
ECOG performance status
Item
ecog performance status 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed Consent
Item
voluntarily provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
you cannot participate in this study if any of the following apply to you:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Peripheral Neuropathy Moderate | Peripheral Neuropathy Severe
Item
moderate or severe peripheral neuropathy
boolean
C0031117 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0031117 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Medical condition Serious Interferes with Protocol Therapeutic procedure
Item
other serious medical conditions that may interfere with protocol therapy
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,5])
Malignant Neoplasms
Item
other active malignancies
boolean
C0006826 (UMLS CUI [1])
Therapeutic procedure Invasive cancer
Item
history of treatment for other invasive cancers within 3 years
boolean
C0087111 (UMLS CUI [1,1])
C0677898 (UMLS CUI [1,2])
Clinical Trial Eligibility Criteria Additional
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial